General Electric is in a liability fight over a rare and sometimes fatal disease that has been linked to a dye used for MRI scans, with a preponderance of cases involving a GE product called Omniscan.

March 7: This post has been updated to incorporate a response from GE. In 1994, a scientist studying her company’s new medical imaging dye reached troubling findings. Her boss, she recalls, told her ...

MINNEAPOLIS (CN) - More than 90 percent of patients diagnosed with nephrogenic systemic fibrosis, a progressive, incurable and potentially deadly disease, received injections of General Electric's ...

Newgen Software, a provider of Business Process Management (BPM), Enterprise Content Management (ECM), and Customer Communication Management (CCM) platforms, announced the release of OmniScan ...

Newgen Software, a global provider of low-code platform, released a new version of its document management solution NewgenONE OmniScan 7.0 that redefines document management in high-volume ...

Newgen Software, a provider of Business Process Management (BPM), Enterprise Content Management (ECM), and Customer Communication Management (CCM) platforms, today announced the release of OmniScan ...

A US corporation, GE Healthcare, has dropped the controversial British libel action it brought against a scientist who criticised one of its drugs, saying the firm did not mean to stifle academic ...

Newgen Software, a leading global provider of Business Process Management (BPM), Enterprise Content Management (ECM), and Customer Communication Management (CCM) solutions, today announced the launch ...

New warnings are in store for three imaging drugs. The FDA says it's requiring Bayer, Covidien and GE Healthcare to change the labels of their gadolinium-based contrast agents to highlight the risk of ...